Fujian Haixi Pharmaceuticals Co Ltd

02637

Company Profile

  • Business description

    Fujian Haixi Pharmaceuticals Co Ltd is a commercial-stage pharmaceutical company that integrates R&D, production and sales capacities, with a pipeline of inventive drug candidates. It has a diversified product portfolio and pipeline in the fastest growing therapeutic areas in China. The company's commercialized product portfolio consisted of generic drugs for digestive system diseases, cardiovascular system diseases, endocrine system diseases, nervous system diseases and inflammatory diseases. Its inventive drug pipeline focuses on drug candidates in a variety of indications, including one potential first-in-class oncology drug candidate, one potential first oral drug therapy for wet age-related macular degeneration /diabetic macular edema /retinal vein occlusion.

  • Contact

    No. 177 Jinda Road
    Floor 3rd & 4th, Block B
    Jianxin Town
    Cangshan District,Fujian Province
    Fuzhou350028
    CHN

    T: +86 59187519936

    https://www.hxpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    203

Stocks News & Analysis

stocks

Chart of the Week: Has gold reached bear market territory?

Investors are facing a shifting landscape.
stocks

ASX share benefiting from favourable industry trends

We anticipate further earnings growth.
stocks

Fair value upgrade for this ASX income player

Headwinds in listed energy stocks likely to have passed

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,885.6059.900.68%
CAC 407,961.80144.861.85%
DAX 4023,190.98510.942.25%
Dow JONES (US)46,341.511,125.372.49%
FTSE 10010,369.23192.781.89%
HKSE25,294.03505.892.04%
NASDAQ21,590.63795.993.83%
Nikkei 22553,739.682,675.965.24%
NZX 50 Index12,825.8786.24-0.67%
S&P 5006,528.52184.802.91%
S&P/ASX 2008,671.8053.100.62%
SSE Composite Index3,948.5556.691.46%

Market Movers